• Home
  • Contact Us
  • Try it!
  • Blog
  • Vizit Graphs

Follow us

Recent Posts

  • Biovista Harnesses New Kinds of Augmented and Artificial Intelligence to Address COVID-19 August 25, 2020
  • Repositioning Safety May 22, 2020
  • Artificial Intelligence firm Biovista repositions four promising therapeutics against COVID-19 April 22, 2020
  • Business Development Agent in Japan February 12, 2020
  • High Throughput Layout and Copy Paste July 5, 2019

Biovista Vizit

Biovista Vizit

  • Try it!
  • Blog
  • Vizit Graphs

GLUCAGON-LIKE PEPTIDE 1

PPARgamma and drugs for Alzheimer’s and Diabetes

September 17, 2018Alzheimer's, Diabetes, Metabolic Disorders, Nervous System Disorders, Vizit Graphs
PPARgamma ad common drugs and two major diseases, Alzheimer’s and Diabetes

“Live graph” of PPARgamma associated with common drugs and two major diseases, Alzheimer’s and Diabetes. Explore the live graph.

Parkinson’s disease and Diabetes Type 2

August 27, 2018Diabetes, Metabolic Disorders, Nervous System Disorders, Parkinson's, Vizit Graphs
Parkinson disease and Diabetes Type 2

Incretin mimetics or GLP-1 receptor agonists are commonly used in Type 2 Diabetes. Recent evidence favors their use for the treatment of Parkinson’s disease. Explore the live graph.

Vizit Graphs Tag Cloud

ESCHERICHIA COLI AGING IL10 RHEUMATOID ARTHRITIS IL2 LISTERIA MONOCYTOGENES CANCER SARS-COV-2 PSEUDOMONAS AERUGINOSA COGNITION IL6 APOPTOTIC PROCESS COAGULATION ACE CASP3 PARKINSON DISEASE IMMUNITY STAPHYLOCOCCUS AUREUS IL1B IMMUNE RESPONSE LACTATE DEHYDROGENASE CANDIDA ALBICANS TNF HELICOBACTER PYLORI IFNG INTERFERON TMPRSS2 AUTOPHAGY INFLAMMATORY RESPONSE CD4 COVID-19 CELL PROLIFERATION ACE2 PD-1 METFORMIN MYALGIA NFKB1 ALBUMIN RAS INSULIN NEUTROPHILS CELL DIFFERENTIATION ANGIOTENSIN II INFLAMMATION ALZHEIMER'S DISEASE

© 2021 Biovista Vizit All Rights Reserved.